[Federal Register Volume 82, Number 43 (Tuesday, March 7, 2017)]
[Notices]
[Pages 12881-12886]
[FR Doc No: 2017-04383]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Motor Carrier Safety Administration

[Docket No. FMCSA-2016-0385]

Qualification of Drivers; Exemption Applications; Diabetes
Mellitus

AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT.

ACTION: Notice of applications for exemptions; request for comments.

-----------------------------------------------------------------------

SUMMARY: FMCSA announces receipt of applications from 28 individuals
for exemption from the prohibition against persons with insulin-treated
diabetes mellitus (ITDM) operating commercial motor vehicles (CMVs) in
interstate commerce. If granted, the exemptions would enable these
individuals with ITDM to operate CMVs in interstate commerce.

DATES: Comments must be received on or before April 6, 2017.

ADDRESSES: You may submit comments bearing the Federal Docket
Management System (FDMS) Docket No. FMCSA-2016-0385 using any of the
following methods:
     Federal eRulemaking Portal: Go to http://www.regulations.gov. Follow the on-line instructions for submitting
comments.
     Mail: Docket Management Facility; U.S. Department of
Transportation, 1200 New Jersey Avenue SE., West Building Ground Floor,
Room W12-140, Washington, DC 20590-0001.
     Hand Delivery: West Building Ground Floor, Room W12-140,
1200 New Jersey Avenue SE., Washington, DC, between 9 a.m. and 5 p.m.,
e.t., Monday through Friday, except Federal Holidays.
     Fax: 1-202-493-2251.
    Instructions: Each submission must include the Agency name and the
docket numbers for this notice. Note that all comments received will be
posted without change to http://www.regulations.gov, including any
personal information provided. Please see the Privacy Act heading below
for further information.
    Docket: For access to the docket to read background documents or

comments, go to http://www.regulations.gov at any time or Room W12-140
on the ground level of the West Building, 1200 New Jersey Avenue SE.,
Washington, DC, between 9 a.m. and 5 p.m., e.t., Monday through Friday,
except Federal holidays. The Federal Docket Management System (FDMS) is
available 24 hours each day, 365 days each year. If you want
acknowledgment that we received your comments, please include a self-
addressed, stamped envelope or postcard or print the acknowledgement
page that appears after submitting comments on-line.
    Privacy Act: In accordance with 5 U.S.C. 553(c), DOT solicits
comments from the public to better inform its rulemaking process. DOT
posts these comments, without edit, including any personal information
the commenter provides, to www.regulations.gov, as described in the
system of records notice (DOT/ALL-14 FDMS), which can be reviewed at
www.dot.gov/privacy.

FOR FURTHER INFORMATION CONTACT: Ms. Christine A. Hydock, Chief,
Medical Programs Division,<PHONE_NUMBER><EMAIL_ADDRESS>FMCSA,
Department of Transportation, 1200 New Jersey Avenue SE., Room W64-113,
Washington, DC 20590-0001. Office hours are 8:30 a.m. to 5 p.m., e.t.,
Monday through Friday, except Federal holidays.

SUPPLEMENTARY INFORMATION:

I. Background

    Under 49 U.S.C. 31136(e) and 31315, FMCSA may grant an exemption
from the Federal Motor Carrier Safety Regulations for a 2-year period
if it finds ``such exemption would likely achieve a level of safety
that is equivalent to or greater than the level that would be achieved
absent such exemption.'' The statute also allows the Agency to renew
exemptions at the end of the 2-year period. The 28 individuals listed
in this notice have recently requested such an exemption from the
diabetes prohibition in 49 CFR 391.41(b) (3), which applies to drivers
of CMVs in interstate commerce. Accordingly, the Agency will evaluate
the qualifications of each applicant to determine whether granting the
exemption will achieve the required level of safety mandated by
statute.

II. Qualifications of Applicants

Larry A. Acton

    Mr. Acton, 58, has had ITDM since 2014. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Acton understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Acton meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Kansas.

Matthew M. Bauer

    Mr. Bauer, 29, has had ITDM since 2016. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Bauer understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Bauer meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds a Class E CDL from Michigan.

Gerald T. Booth

    Mr. Booth, 69, has had ITDM since 2006. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Booth understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Booth meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from New York.

Jeremy D. Carpenter

    Mr. Carpenter, 28, has had ITDM since 2014. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Carpenter understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Carpenter meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds an operator's license from Alabama.

David L. Carraway

    Mr. Carraway, 60, has had ITDM since 2015. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Carraway understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Carraway meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from North Carolina.

Mitchell S. Crites

    Mr. Crites, 21, has had ITDM since 2007. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Crites understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Crites meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Ohio.

Martin K. Dennis

    Mr. Dennis, 49, has had ITDM since 2010. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting

in loss of consciousness, requiring the assistance of another person,
or resulting in impaired cognitive function that occurred without
warning in the past 12 months and no recurrent (2 or more) severe
hypoglycemic episodes in the last 5 years. His endocrinologist
certifies that Mr. Dennis understands diabetes management and
monitoring, has stable control of his diabetes using insulin, and is
able to drive a CMV safely. Mr. Dennis meets the requirements of the
vision standard at 49 CFR 391.41(b)(10). His optometrist examined him
in 2016 and certified that he does not have diabetic retinopathy. He
holds an operator's license from Pennsylvania.

Ryan E. Dickinson

    Mr. Dickinson, 37, has had ITDM since 2016. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Dickinson understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Dickinson meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from New York.

John T. Edmiston

    Mr. Edmiston, 41, has had ITDM since 2002. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Edmiston understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Edmiston meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds an operator's license from Texas.

Malcolm C. Ferriell

    Mr. Ferriell, 66, has had ITDM since 2016. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Ferriell understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Ferriell meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Indiana.

Saul Gates, III

    Mr. Gates, 59, has had ITDM since 2005. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Gates understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Gates meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2016 and certified that he has stable
nonproliferative diabetic retinopathy. He holds a Class B CDL from
Texas.

Paul S. Hare

    Mr. Hare, 46, has had ITDM since 2008. His endocrinologist examined
him in 2016 and certified that he has had no severe hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in the last 5 years. His
endocrinologist certifies that Mr. Hare understands diabetes management
and monitoring, has stable control of his diabetes using insulin, and
is able to drive a CMV safely. Mr. Hare meets the requirements of the
vision standard at 49 CFR 391.41(b)(10). His optometrist examined him
in 2016 and certified that he does not have diabetic retinopathy. He
holds an operator's license from Virginia.

Jimmie E. Johnson

    Mr. Johnson, 65, has had ITDM since 2012. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Johnson understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Johnson meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2016 and certified that he does not
have diabetic retinopathy. He holds a Class A CDL from Indiana.

Ronald A. Karr

    Mr. Karr, 62, has had ITDM since 2016. His endocrinologist examined
him in 2016 and certified that he has had no severe hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in the last 5 years. His
endocrinologist certifies that Mr. Karr understands diabetes management
and monitoring, has stable control of his diabetes using insulin, and
is able to drive a CMV safely. Mr. Karr meets the requirements of the
vision standard at 49 CFR 391.41(b)(10). His optometrist examined him
in 2016 and certified that he does not have diabetic retinopathy. He
holds a Class A CDL from South Dakota.

David A. Morrill

    Mr. Morrill, 68, has had ITDM since 2014. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Morrill understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Morrill meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist

examined him in 2016 and certified that he does not have diabetic
retinopathy. He holds a Class A CDL from Maine.

Parker L. Pearce

    Mr. Pearce, 27, has had ITDM since 1998. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Pearce understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Pearce meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2016 and certified that he does not
have diabetic retinopathy. He holds an operator's license from Texas.

Raymond L. Ramsey

    Mr. Ramsey, 59, has had ITDM since 2000. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Ramsey understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Ramsey meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2016 and certified that he has stable
nonproliferative diabetic retinopathy. He holds a Class A CDL from New
Hampshire.

Ronald A. Routh

    Mr. Routh, 67, has had ITDM since 2012. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Routh understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Routh meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2016 and certified that he does not
have diabetic retinopathy. He holds a Class A CDL from Oklahoma.

Sean R. Shakespeare

    Mr. Shakespeare, 23, has had ITDM since 2000. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Shakespeare understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Shakespeare meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds an operator's license from Nevada.

Ryan B. Silva

    Mr. Silva, 27, has had ITDM since 2001. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Silva understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Silva meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2016 and certified that he does not
have diabetic retinopathy. He holds an operator's license from
Massachusetts.

Kent A. Smith

    Mr. Smith, 59, has had ITDM since 2015. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Smith understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Smith meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Kansas.

Zachary C. Smith

    Mr. Smith, 23, has had ITDM since 2016. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. [Name] understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Smith meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Montana.

Jennifer S. Starr

    Ms. Starr, 50, has had ITDM since 2014. Her endocrinologist
examined her in 2016 and certified that she has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
Her endocrinologist certifies that Ms. Starr understands diabetes
management and monitoring has stable control of her diabetes using
insulin, and is able to drive a CMV safely. Ms. Starr meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). Her
ophthalmologist examined her in 2016 and certified that she has stable
nonproliferative diabetic retinopathy. She holds a Class A CDL from
Oregon.

Benjamin T. Weinheimer, Jr.

    Mr. Weinheimer, 23, has had ITDM since 1995. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more)

severe hypoglycemic episodes in the last 5 years. His endocrinologist
certifies that Mr. Weinheimer understands diabetes management and
monitoring, has stable control of his diabetes using insulin, and is
able to drive a CMV safely. Mr. Weinheimer meets the requirements of
the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist
examined him in 2016 and certified that he has stable nonproliferative
diabetic retinopathy. He holds an operator's license from Texas.

Walter D. West

    Mr. West, 59, has had ITDM since 1998. His endocrinologist examined
him in 2016 and certified that he has had no severe hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in the last 5 years. His
endocrinologist certifies that Mr. West understands diabetes management
and monitoring, has stable control of his diabetes using insulin, and
is able to drive a CMV safely. Mr. West meets the requirements of the
vision standard at 49 CFR 391.41(b)(10). His optometrist examined him
in 2016 and certified that he does not have diabetic retinopathy. He
holds a Class A CDL from Missouri.

John K. Windler

    Mr. Windler, 62, has had ITDM since 2016. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Windler understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Windler meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Indiana.

Kathy A. Wofford

    Ms. Wofford, 38, has had ITDM since 2001. Her endocrinologist
examined her in 2016 and certified that she has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
Her endocrinologist certifies that Ms. Wofford understands diabetes
management and monitoring has stable control of her diabetes using
insulin, and is able to drive a CMV safely. Ms. Wofford meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). Her
optometrist examined her in 2017 and certified that she does not have
diabetic retinopathy. She holds a Class B CDL from Georgia.

Shawn L. Wood

    Mr. Wood, 44, has had ITDM since 2014. His endocrinologist examined
him in 2016 and certified that he has had no severe hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in the last 5 years. His
endocrinologist certifies that Mr. Wood understands diabetes management
and monitoring, has stable control of his diabetes using insulin, and
is able to drive a CMV safely. Mr. Wood meets the requirements of the
vision standard at 49 CFR 391.41(b)(10). His optometrist examined him
in 2016 and certified that he does not have diabetic retinopathy. He
holds a Class A CDL from Colorado.

III. Request for Comments

    In accordance with 49 U.S.C. 31136(e) and 31315, FMCSA requests
public comment from all interested persons on the exemption petitions
described in this notice. We will consider all comments received before
the close of business on the closing date indicated in the date section
of the notice.
    FMCSA notes that section 4129 of the Safe, Accountable, Flexible
and Efficient Transportation Equity Act: A Legacy for Users requires
the Secretary to revise its diabetes exemption program established on
September 3, 2003 (68 FR 52441).\1\ The revision must provide for
individual assessment of drivers with diabetes mellitus, and be
consistent with the criteria described in section 4018 of the
Transportation Equity Act for the 21st Century (49 U.S.C. 31305).
---------------------------------------------------------------------------

    \1\ Section 4129(a) refers to the 2003 notice as a ``final
rule.'' However, the 2003 notice did not issue a ``final rule'' but
did establish the procedures and standards for issuing exemptions
for drivers with ITDM.
---------------------------------------------------------------------------

    Section 4129 requires: (1) Elimination of the requirement for 3
years of experience operating CMVs while being treated with insulin;
and (2) establishment of a specified minimum period of insulin use to
demonstrate stable control of diabetes before being allowed to operate
a CMV.
    In response to section 4129, FMCSA made immediate revisions to the
diabetes exemption program established by the September 3, 2003 notice.
FMCSA discontinued use of the 3-year driving experience and fulfilled
the requirements of section 4129 while continuing to ensure that
operation of CMVs by drivers with ITDM will achieve the requisite level
of safety required of all exemptions granted under 49 U.S.C. 31136 (e).
    Section 4129(d) also directed FMCSA to ensure that drivers of CMVs
with ITDM are not held to a higher standard than other drivers, with
the exception of limited operating, monitoring and medical requirements
that are deemed medically necessary.
    The FMCSA concluded that all of the operating, monitoring and
medical requirements set out in the September 3, 2003 notice, except as
modified, were in compliance with section 4129(d). Therefore, all of
the requirements set out in the September 3, 2003 notice, except as
modified by the notice in the Federal Register on November 8, 2005 (70
FR 67777), remain in effect.

IV. Submitting Comments

    You may submit your comments and material online or by fax, mail,
or hand delivery, but please use only one of these means. FMCSA
recommends that you include your name and a mailing address, an email
address, or a phone number in the body of your document so that FMCSA
can contact you if there are questions regarding your submission.
    To submit your comment online, go to http://www.regulations.gov and
in the search box insert the docket number FMCSA-2016-0385 and click
the search button. When the new screen appears, click on the blue
``Comment Now!'' button on the right hand side of the page. On the new
page, enter information required including the specific section of this
document to which each comment applies, and provide a reason for each
suggestion or recommendation. If you submit your comments by mail or
hand delivery, submit them in an unbound format, no larger than 8\1/2\
by 11 inches, suitable for copying and electronic filing. If you submit
comments by mail and would like to know that they reached the facility,
please enclose a stamped, self-addressed postcard or envelope.
    We will consider all comments and material received during the
comment period. FMCSA may issue a final

determination at any time after the close of the comment period.

V. Viewing Comments and Documents

    To view comments, as well as any documents mentioned in this
preamble, go to http://www.regulations.gov and in the search box insert
the docket number FMCSA-2016-0385 and click ``Search.'' Next, click
``Open Docket Folder'' and you will find all documents and comments
related to this notice.

    Issued on: February 28, 2017
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2017-04383 Filed 3-6-17; 8:45 am]
 BILLING CODE 4910-EX-P


[Federal Register: January 27, 2010 (Volume 75, Number 17)]
[Notices]
[Page 4384-4389]
[DOCID:fr27ja10-82]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OPP-2009-0788; FRL-8796-2]

Pesticide Products; Registration Applications

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice announces receipt of applications to register
pesticide products containing new active ingredients not included in
any currently registered products pursuant to the provisions of section
3(c)(4) of the Federal Insecticide, Fungicide, and Rodenticide Act
(FIFRA), as amended.

DATES: Comments must be received on or before February 26, 2010.

ADDRESSES: Submit your comments, identified by the docket
identification (ID) number and the file symbol for the pesticide of
interest as shown in the registration application summary, by one of
the following methods:
     Federal eRulemaking Portal: http://www.regulations.gov.
Follow the on-line instructions for submitting comments.
     Mail: Office of Pesticide Programs (OPP) Regulatory Public
Docket (7502P), Environmental Protection Agency, 1200 Pennsylvania
Ave., NW., Washington, DC 20460-0001.
     Delivery: OPP Regulatory Public Docket (7502P),
Environmental Protection Agency, Rm. S-4400, One Potomac Yard (South
Bldg.), 2777 S. Crystal Dr., Arlington, VA. Deliveries are only
accepted during the Docket Facility's normal hours of operation

(8:30 a.m. to 4 p.m., Monday through Friday, excluding legal holidays).
Special arrangements should be made for deliveries of boxed
information. The Docket Facility telephone number is<PHONE_NUMBER>.
    Instructions: Direct your comments to the docket ID number
specified for the pesticide of interest as shown in the registration
application summaries. EPA's policy is that all comments received will
be included in the docket without change and may be made available on-
line at http://www.regulations.gov, including any personal information
provided, unless the comment includes information claimed to be
Confidential Business Information (CBI) or other information whose
disclosure is restricted by statute. Do not submit information that you
consider to be CBI or otherwise protected through regulations.gov or e-
mail. The regulations.gov website is an ``anonymous access'' system,
which means EPA will not know your identity or contact information
unless you provide it in the body of your comment. If you send an e-
mail comment directly to EPA without going through regulations.gov,
your e-mail address will be automatically captured and included as part
of the comment that is placed in the docket and made available on the
Internet. If you submit an electronic comment, EPA recommends that you
include your name and other contact information in the body of your
comment and with any disk or CD-ROM you submit. If EPA cannot read your
comment due to technical difficulties and cannot contact you for
clarification, EPA may not be able to consider your comment. Electronic
files should avoid the use of special characters, any form of
encryption, and be free of any defects or viruses.
    Docket: All documents in the docket are listed in the docket index
available at http://www.regulations.gov. Although listed in the index,
some information is not publicly available, e.g., CBI or other
information whose disclosure is restricted by statute. Certain other
material, such as copyrighted material, is not placed on the Internet
and will be publicly available only in hard copy form. Publicly
available docket materials are available either in the electronic
docket at http://www.regulations.gov, or, if only available in hard
copy, at the OPP Regulatory Public Docket in Rm. S-4400, One Potomac
Yard (South Bldg.), 2777 S. Crystal Dr., Arlington, VA. The hours of
operation of this Docket Facility are from 8:30 a.m. to 4 p.m., Monday
through Friday, excluding legal holidays. The Docket Facility telephone
number is<PHONE_NUMBER>.

FOR FURTHER INFORMATION CONTACT:  A contact person is listed at the end
of each registration application summary and may be contacted by mail,
telephone or email. The mailing address for each contact person listed
is: Registration Division (7505P), Office of Pesticide Programs,
Environmental Protection Agency, 1200 Pennsylvania Ave., NW.,
Washington, DC 20460-0001.

SUPPLEMENTARY INFORMATION:

I. General Information

A. Does this Action Apply to Me?

    You may be potentially affected by this action if you are an
agricultural producer, food manufacturer, or pesticide manufacturer.
Potentially affected entities may include, but are not limited to:
     Crop production (NAICS code 111).
     Animal production (NAICS code 112).
     Food manufacturing (NAICS code 311).
     Pesticide manufacturing (NAICS code 32532).
    This listing is not intended to be exhaustive, but rather provides
a guide for readers regarding entities likely to be affected by this
action. Other types of entities not listed in this unit could also be
affected. The North American Industrial Classification System (NAICS)
codes have been provided to assist you and others in determining
whether this action might apply to certain entities. If you have any
questions regarding the applicability of this action to a particular
entity, consult the person listed under FOR FURTHER INFORMATION
CONTACT.

B. What Should I Consider as I Prepare My Comments for EPA?

     1. Submitting CBI. Do not submit this information to EPA through
regulations.gov or e-mail. Clearly mark the part or all of the
information that you claim to be CBI. For CBI information in a disk or
CD-ROM that you mail to EPA, mark the outside of the disk or CD-ROM as
CBI and then identify electronically within the disk or CD-ROM the
specific information that is claimed as CBI. In addition to one
complete version of the comment that includes information claimed as
CBI, a copy of the comment that does not contain the information
claimed as CBI must be submitted for inclusion in the public docket.
Information so marked will not be disclosed except in accordance with
procedures set forth in 40 CFR part 2.
    2. Tips for preparing your comments. When submitting comments,
remember to:
    i. Identify the document by docket ID number and other identifying
information (subject heading, Federal Register date and page number).
If you are commenting in a docket that addresses multiple products,
please indicate to which file symbol(s) your comment applies.
     ii. Follow directions. The Agency may ask you to respond to
specific questions or organize comments by referencing a Code of
Federal Regulations (CFR) part or section number.
    iii. Explain why you agree or disagree; suggest alternatives and
substitute language for your requested changes.
     iv. Describe any assumptions and provide any technical information
and/or data that you used.
    v. If you estimate potential costs or burdens, explain how you
arrived at your estimate in sufficient detail to allow for it to be
reproduced.
    vi. Provide specific examples to illustrate your concerns and
suggest alternatives.
    vii. Explain your views as clearly as possible, avoiding the use of
profanity or personal threats.
     viii. Make sure to submit your comments by the comment period
deadline identified.

II. Registration Applications

    EPA received applications as follows to register pesticide products
containing active ingredients not included in any previously registered
products pursuant to the provision of section 3(c)(4) of FIFRA. Notice
of receipt of these applications does not imply a decision by the
Agency on the applications.
    1. File Symbol: 264-RRNL. Docket Number: EPA-HQ-OPP-2009-0636.
Applicant: Bayer CropScience, LP, P.O. Box 12014, 2 T.W. Alexander
Drive, Research Triangle Park, NC 27709. Product name: Indaziflam 500
SC Herbicide. Active ingredient: Herbicide with Indaziflam at 45.05%.
Proposed use: Pre-emergent control of annual grasses and broadleaf
weeds in citrus fruits, stone fruits, pome fruits, grapes, tree nuts,
pistachios, olives, and also for sugarcane grown in and imported from
Brazil. Contact: Bethany Benbow,<PHONE_NUMBER><EMAIL_ADDRESS>    2. File Symbol: 264-RRNA. Docket Number: EPA-HQ-OPP-2009-0636.
Applicant: Bayer CropScience, LP, P.O. Box 12014, 2 T.W. Alexander
Drive, Research Triangle Park, NC 27709. Product name: Indaziflam 200
SC Herbicide. Active ingredient: Herbicide with Indaziflam at 19.05%.
Proposed use: Preemergent control of annual

grasses and broadleaf weeds in citrus fruit, stone fruit, pome fruit,
grapes, tree nuts, pistachios, and olives. Contact: Bethany Benbow,
(703) 347-8072<EMAIL_ADDRESS>    3. File Symbol: 352-TIE. Docket Number: EPA-HQ-OPP-2009-0789.
Applicant: E. I. du Pont de Nemours and Company, DuPont Crop
Protection, Stine-Haskell Research Center, P.O. Box 30, Newark, DE
19714. Product name: DPX-MAT28 Technical Herbicide. Active ingredient:
Herbicide with Aminocyclopyrachlor at 89.3%. Proposed use: For
formulation into an end-use herbicide for use in terrestrial non-crop
areas and outdoor domestic landscape turf grass. Contact: Mindy Ondish,
(703) 605-0723<EMAIL_ADDRESS>    4. File Symbol: 352-TIG. Docket Number: EPA-HQ-OPP-2009-0789.
Applicant: E. I. du Pont de Nemours and Company, DuPont Crop
Protection, Stine-Haskell Research Center, P.O. Box 30, Newark, DE
19714. Product name: DPX-KJM44 Technical Herbicide. Active ingredient:
Herbicide with Aminocyclopyrachlor methyl at 95.6%. Proposed use: For
formulation into an end-use herbicide for use in terrestrial non-crop
areas and outdoor domestic landscape turf grass. Contact: Mindy Ondish,
(703) 605-723<EMAIL_ADDRESS>    5. File Symbol: 352-TIU. Docket Number: EPA-HQ-OPP-2009-0789.
Applicant: E. I. du Pont de Nemours and Company, DuPont Crop
Protection, Stine-Haskell Research Center, P.O. Box 30, Newark, DE
19714. Product name: DPX-KJM44 80 MUP Herbicide. Active ingredient:
Herbicide with Aminocyclopyrachlor methyl at 80.0%. Proposed use: For
formulation into an end-use herbicide for use in terrestrial non-crop
areas and outdoor domestic landscape turf grass. Contact: Mindy Ondish,
(703) 605-0723<EMAIL_ADDRESS>    6. File Symbol: 352-TIL. Docket Number: EPA-HQ-OPP-2009-0789.
Applicant: E. I. du Pont de Nemours and Company, 1007 Market Street,
Wilmington, DE 19898. Product name: DPX-KJM44 80XP Herbicide. Active
ingredient: Herbicide with Aminocyclopyrachlor methyl at 80.0%.
Proposed use: Weed control of broadleaf weeds and woody plants in
terrestrial non-crop areas and unimproved turf sites. Contact: Mindy
Ondish,<PHONE_NUMBER><EMAIL_ADDRESS>    7. File Symbol: 352-TIA. Docket Number: EPA-HQ-OPP-2009-0789.
Applicant: E. I. du Pont de Nemours and Company, DuPont Crop
Protection, Stine-Haskell Research Center, P.O. Box 30, Newark, DE
19714. Product name: DPX-MAT28 240SL Herbicide. Active ingredient:
Herbicide with Aminocyclopyrachlor, potassium salt at 24.0%. Proposed
use: Weed control of broadleaf weeds and woody plants in terrestrial
non-crop areas and unimproved turf sites. Contact: Mindy Ondish, (703)
605-0723<EMAIL_ADDRESS>    8. File Symbol: 352-TIT. Docket Number: EPA-HQ-OPP-2009-0789.
Applicant: E. I. du Pont de Nemours and Company, DuPont Crop
Protection, Stine-Haskell Research Center, P.O. Box 30, Newark, DE
19714. Product name: DPX-MAT28 50SG Herbicide. Active ingredient:
Herbicide with Aminocyclopyrachlor at 50.0%. Proposed use: Weed control
of broadleaf weeds and woody plants in terrestrial non-crop areas and
unimproved turf sites. Contact: Mindy Ondish,<PHONE_NUMBER>,
<EMAIL_ADDRESS>    9. File Symbol: 352-TII. Docket Number: EPA-HQ-OPP-2009-0789.
Applicant: E. I. du Pont de Nemours and Company, DuPont Crop
Protection, Stine-Haskell Research Center, P.O. Box 30, Newark, DE
19714. Product name: DPX-Q2B37 Herbicide. Active ingredient: Herbicide
with Aminocyclopyrachlor methyl at 42.1%, Chlorsulfuron at 11.9%, and
Sulfometuron at 23.7%. Proposed use: Weed control of broadleaf weeds
and grasses in terrestrial non-crop areas. Contact: Mindy Ondish, (703)
605-0723<EMAIL_ADDRESS>    10. File Symbol: 352-TIO. Docket Number: EPA-HQ-OPP-2009-0789.
Applicant: E. I. du Pont de Nemours and Company, DuPont Crop
Protection, Stine-Haskell Research Center, P.O. Box 30, Newark, DE
19714. Product name: DPX-Q2B38 Herbicide. Active ingredient: Herbicide
with Aminocyclopyrachlor methyl at 28.7%, Imazapyr at 37.3%, and
Metsulfuron at 8.6%. Proposed use: Weed control of broadleaf weeds and
woody plants in terrestrial non-crop areas. Contact: Mindy Ondish,
(703) 605-0723<EMAIL_ADDRESS>    11. File Symbol: 352-TON. Docket Number: EPA-HQ-OPP-2009-0789.
Applicant: E. I. du Pont de Nemours and Company, DuPont Crop
Protection, Stine-Haskell Research Center, P.O. Box 30, Newark, DE
19714. Product name: DPX-Q2B39 Herbicide. Active ingredient: Herbicide
with Aminocyclopyrachlor methyl at 57.1% and Metsulfuron at 11.2%.
Proposed use: Weed control of broadleaf weeds and woody plants in
terrestrial non-crop areas. Contact: Mindy Ondish,<PHONE_NUMBER>,
<EMAIL_ADDRESS>    12. File Symbol: 352-TOR. Docket Number: EPA-HQ-OPP-2009-0789.
Applicant: E. I. du Pont de Nemours and Company, DuPont Crop
Protection, Stine-Haskell Research Center, P.O. Box 30, Newark, DE
19714. Product name: DPX-QKJ02 Herbicide. Active ingredient: Herbicide
with Aminocyclopyrachlor methyl at 57.1% and Chlorsulfuron at 21.4%.
Proposed use: Broadleaf weed control in terrestrial non-crop areas and
unimproved turf sites. Contact: Mindy Ondish,<PHONE_NUMBER>,
<EMAIL_ADDRESS>    13. File Symbol: 352-TOE. Docket Number: EPA-HQ-OPP-2009-0789.
Applicant: E.I. du Pont de Nemours and Company, DuPont Crop Protection,
Stine-Haskell Research Center, P.O. Box 30, Newark, DE 19714. Product
name: DPX-KJM44 80XP Herbicide. Active ingredient: Herbicide with
Aminocyclopyrachlor methyl at 80.0%. Proposed use: Selective broadleaf
weed control in cool and warm season turfgrasses. Contact: Mindy
Ondish,<PHONE_NUMBER><EMAIL_ADDRESS>    14. File Symbol: 352-TOG. Docket Number: EPA-HQ-OPP-2009-0789.
Applicant: E. I. du Pont de Nemours and Company, DuPont Crop
Protection, Stine-Haskell Research Center, P.O. Box 30, Newark, DE
19714. Product name: DPX-MAT28 240SL Turf Herbicide. Active ingredient:
Herbicide with Aminocyclopyrachlor, potassium salt at 24.0%. Proposed
use: Selective broadleaf weed control in cool and warm season
turfgrasses. Contact: Mindy Ondish,<PHONE_NUMBER>,
<EMAIL_ADDRESS>    15. File Symbol: 352-TOU. Docket Number: EPA-HQ-OPP-2009-0789.
Applicant: E. I. du Pont de Nemours and Company, DuPont Crop
Protection, Stine-Haskell Research Center, P.O. Box 30, Newark, DE
19714. Product name: DPX-MAT28 50SG Turf Herbicide. Active ingredient:
Herbicide with Aminocyclopyrachlor at 50.0%. Proposed use: Selective
broadleaf weed control in cool and warm season turfgrasses. Contact:
Mindy Ondish,<PHONE_NUMBER><EMAIL_ADDRESS>    16. File Symbol: 352-TOL. Docket Number: EPA-HQ-OPP-2009-0789.
Applicant: E. I. du Pont de Nemours and Company, DuPont Crop
Protection, Stine-Haskell Research Center, P.O. Box 30, Newark, DE
19714. Product name: DPX-KJM44 10% Manufacturing Concentrate. Active
ingredient: Herbicide with Aminocyclopyrachlor methyl at 10.0%.
Proposed use: For formulation into an end-use herbicide for use in
terrestrial non-crop areas and outdoor domestic landscape turf grass.
Contact: Mindy Ondish,<PHONE_NUMBER><EMAIL_ADDRESS>

    17. File Symbol: 352-TOA. Docket Number: EPA-HQ-OPP-2009-0789.
Applicant: E. I. du Pont de Nemours and Company, DuPont Crop
Protection, Stine-Haskell Research Center, P.O. Box 30, Newark, DE
19714. Product name: DPX-MAT28 10% Manufacturing Concentrate. Active
ingredient: Herbicide with Aminocyclopyrachlor at 10.0%. Proposed use:
For formulation into an end-use herbicide for use in terrestrial non-
crop areas and outdoor domestic landscape turf grass. Contact: Mindy
Ondish,<PHONE_NUMBER><EMAIL_ADDRESS>    18. File Symbol: 352-TOT. Docket Number: EPA-HQ-OPP-2009-0789.
Applicant: E. I. du Pont de Nemours and Company, DuPont Crop
Protection, Stine-Haskell Research Center, P.O. Box 30, Newark, DE
19714. Product name: DPX-KJM44 0.064G Turf Herbicide + Fertilizer.
Active ingredient: Herbicide with Aminocyclopyrachlor methyl at 0.064%.
Proposed use: Selective broadleaf weed control in cool and warm season
turfgrasses. Contact: Mindy Ondish,<PHONE_NUMBER>,
<EMAIL_ADDRESS>    19. File Symbol: 352-TOI. Docket Number: EPA-HQ-OPP-2009-0789.
Applicant: E. I. du Pont de Nemours and Company, DuPont Crop
Protection, Stine-Haskell Research Center, P.O. Box 30, Newark, DE
19714. Product name: DPX-KJM44 0.053G Turf Herbicide + Fertilizer.
Active ingredient: Herbicide with Aminocyclopyrachlor methyl at 0.053%.
Proposed use: Selective broadleaf weed control in cool and warm season
turfgrasses. Contact: Mindy Ondish,<PHONE_NUMBER>,
<EMAIL_ADDRESS>    20. File Symbol: 352-TOO. Docket Number: EPA-HQ-OPP-2009-0789.
Applicant: E. I. du Pont de Nemours and Company, DuPont Crop
Protection, Stine-Haskell Research Center, P.O. Box 30, Newark, DE
19714. Product name: DPX-KJM44 0.032G Turf Herbicide + Fertilizer.
Active ingredient: Herbicide with Aminocyclopyrachlor methyl at 0.032%.
Proposed use: Selective broadleaf weed control in cool and warm season
turfgrasses. Contact: Mindy Ondish,<PHONE_NUMBER>,
<EMAIL_ADDRESS>    21. File Symbol: 352-INN. Docket Number: EPA-HQ-OPP-2009-0789.
Applicant: E. I. du Pont de Nemours and Company, DuPont Crop
Protection, Stine-Haskell Research Center, P.O. Box 30, Newark, DE
19714. Product name: DPX-KJM44 0.073G Lawn Herbicide + Fertilizer.
Active ingredient: Herbicide with Aminocyclopyrachlor methyl at 0.073%.
Proposed use: Broadleaf weed control in residential lawns. Contact:
Mindy Ondish,<PHONE_NUMBER><EMAIL_ADDRESS>    22. File Symbol: 352-INR. Docket Number: EPA-HQ-OPP-2009-0789.
Applicant: E. I. du Pont de Nemours and Company, DuPont Crop
Protection, Stine-Haskell Research Center, P.O. Box 30, Newark, DE
19714. Product name: DPX-KJM44 0.065G Lawn Herbicide + Fertilizer.
Active ingredient: Herbicide with Aminocyclopyrachlor methyl at 0.065%.
Proposed use: Broadleaf weed control in residential lawns. Contact:
Mindy Ondish,<PHONE_NUMBER><EMAIL_ADDRESS>    23. File Symbol: 352-INE. Docket Number: EPA-HQ-OPP-2009-0789.
Applicant: E. I. du Pont de Nemours and Company, DuPont Crop
Protection, Stine-Haskell Research Center, P.O. Box 30, Newark, DE
19714. Product name: DPX-KJM44 0.059G Lawn Herbicide + Fertilizer.
Active ingredient: Herbicide with Aminocyclopyrachlor methyl at 0.059%.
Proposed use: Broadleaf weed control in residential lawns. Contact:
Mindy Ondish,<PHONE_NUMBER><EMAIL_ADDRESS>    24. File Symbol: 352-ING. Docket Number: EPA-HQ-OPP-2009-0789.
Applicant: E. I. du Pont de Nemours and Company, DuPont Crop
Protection, Stine-Haskell Research Center, P.O. Box 30, Newark, DE
19714. Product name: DPX-KJM44 0.053G Lawn Herbicide + Fertilizer.
Active ingredient: Herbicide with Aminocyclopyrachlor methyl at 0.053%.
Proposed use: Broadleaf weed control in residential lawns. Contact:
Mindy Ondish,<PHONE_NUMBER><EMAIL_ADDRESS>    25. File Symbol: 352-INU. Docket Number: EPA-HQ-OPP-2009-0789.
Applicant: E. I. du Pont de Nemours and Company, DuPont Crop
Protection, Stine-Haskell Research Center, P.O. Box 30, Newark, DE
19714. Product name: DPX-KJM44 0.049G Lawn Herbicide + Fertilizer.
Active ingredient: Herbicide with Aminocyclopyrachlor methyl at 0.049%.
Proposed use: Broadleaf weed control in residential lawns. Contact:
Mindy Ondish,<PHONE_NUMBER><EMAIL_ADDRESS>    26. File Symbol: 352-INL. Docket Number: EPA-HQ-OPP-2009-0789.
Applicant: E. I. du Pont de Nemours and Company, DuPont Crop
Protection, Stine-Haskell Research Center, P.O. Box 30, Newark, DE
19714. Product name: DPX-KJM44 0.039G Lawn Herbicide + Fertilizer.
Active ingredient: Herbicide with Aminocyclopyrachlor methyl at 0.039%.
Proposed use: Broadleaf weed control in residential lawns. Contact:
Mindy Ondish,<PHONE_NUMBER><EMAIL_ADDRESS>    27. File Symbol: 352-INA. Docket Number: EPA-HQ-OPP-2009-0789.
Applicant: E. I. du Pont de Nemours and Company, DuPont Crop
Protection, Stine-Haskell Research Center, P.O. Box 30, Newark, DE
19714. Product name: DPX-KJM44 0.037G Lawn Herbicide + Fertilizer.
Active ingredient: Herbicide with Aminocyclopyrachlor methyl at 0.037%.
Proposed use: Broadleaf weed control in residential lawns. Contact:
Mindy Ondish,<PHONE_NUMBER><EMAIL_ADDRESS>    28. File Symbol: 352-INT. Docket Number: EPA-HQ-OPP-2009-0789.
Applicant: E. I. du Pont de Nemours and Company, DuPont Crop
Protection, Stine-Haskell Research Center, P.O. Box 30, Newark, DE
19714. Product name: DPX-KJM44 0.033G Lawn Herbicide + Fertilizer.
Active ingredient: Herbicide with Aminocyclopyrachlor methyl at 0.033%.
Proposed use: Broadleaf weed control in residential lawns. Contact:
Mindy Ondish,<PHONE_NUMBER><EMAIL_ADDRESS>    29. File Symbol: 352-INI. Docket Number: EPA-HQ-OPP-2009-0789.
Applicant: E. I. du Pont de Nemours and Company, DuPont Crop
Protection, Stine-Haskell Research Center, P.O. Box 30, Newark, DE
19714. Product name: DPX-KJM44 0.03G Lawn Herbicide + Fertilizer.
Active ingredient: Herbicide with Aminocyclopyrachlor methyl at 0.03%.
Proposed use: Broadleaf weed control in residential lawns. Contact:
Mindy Ondish,<PHONE_NUMBER><EMAIL_ADDRESS>    30. File Symbol: 352-INO. Docket Number: EPA-HQ-OPP-2009-0789.
Applicant: E. I. du Pont de Nemours and Company, DuPont Crop
Protection, Stine-Haskell Research Center, P.O. Box 30, Newark, DE
19714. Product name: DPX-KJM44 0.027G Lawn Herbicide + Fertilizer.
Active ingredient: Herbicide with Aminocyclopyrachlor methyl at 0.027%.
Proposed use: Broadleaf weed control in residential lawns. Contact:
Mindy Ondish,<PHONE_NUMBER><EMAIL_ADDRESS>    31. File Symbol: 352-IRN. Docket Number: EPA-HQ-OPP-2009-0789.
Applicant: E. I. du Pont de Nemours and Company, DuPont Crop
Protection, Stine-Haskell Research Center, P.O. Box 30, Newark, DE
19714. Product name: DPX-KJM44 0.024G Lawn Herbicide + Fertilizer.
Active ingredient: Herbicide with Aminocyclopyrachlor methyl at 0.024%.
Proposed use: Broadleaf weed control in residential lawns. Contact:
Mindy Ondish,<PHONE_NUMBER><EMAIL_ADDRESS>    32. File Symbol: 352-IRR. Docket Number: EPA-HQ-OPP-2009-0789.
Applicant: E. I. du Pont de Nemours and Company, DuPont Crop
Protection, Stine-Haskell Research Center, P.O. Box 30, Newark, DE
19714. Product name:

DPX-KJM44 0.02G Lawn Herbicide + Fertilizer. Active ingredient:
Herbicide with Aminocyclopyrachlor methyl at 0.02%. Proposed use:
Broadleaf weed control in residential lawns. Contact: Mindy Ondish,
(703) 605-0723<EMAIL_ADDRESS>    33. File Symbol: 352-IRE. Docket Number: EPA-HQ-OPP-2009-0789.
Applicant: E. I. du Pont de Nemours and Company, DuPont Crop
Protection, Stine-Haskell Research Center, P.O. Box 30, Newark, DE
19714. Product name: DPX-MAT28 0.06G Turf Herbicide + Fertilizer.
Active ingredient: Herbicide with Aminocyclopyrachlor at 0.06%.
Proposed use: Selective broadleaf weed control in cool and warm season
turfgrasses. Contact: Mindy Ondish,<PHONE_NUMBER>,
<EMAIL_ADDRESS>    34. File Symbol: 352-RG. Docket Number: EPA-HQ-OPP-2009-0789.
Applicant: E. I. du Pont de Nemours and Company, DuPont Crop
Protection, Stine-Haskell Research Center, P.O. Box 30, Newark, DE
19714. Product name: DPX-MAT28 0.05G Turf Herbicide + Fertilizer.
Active ingredient: Herbicide with Aminocyclopyrachlor at 0.05%.
Proposed use: Selective broadleaf weed control in cool and warm season
turfgrasses. Contact: Mindy Ondish,<PHONE_NUMBER>,
<EMAIL_ADDRESS>    35. File Symbol: 352-IRU. Docket Number: EPA-HQ-OPP-2009-0789.
Applicant: E. I. du Pont de Nemours and Company, DuPont Crop
Protection, Stine-Haskell Research Center, P.O. Box 30, Newark, DE
19714. Product name: DPX-MAT28 0.03G Turf Herbicide + Fertilizer.
Active ingredient: Herbicide with Aminocyclopyrachlor at 0.03%.
Proposed use: Selective broadleaf weed control in cool and warm season
turfgrasses. Contact: Mindy Ondish,<PHONE_NUMBER>,
<EMAIL_ADDRESS>    36. File Symbol: 352-IRL. Docket Number: EPA-HQ-OPP-2009-0789.
Applicant: E. I. du Pont de Nemours and Company, DuPont Crop
Protection, Stine-Haskell Research Center, P.O. Box 30, Newark, DE
19714. Product name: DPX-MAT28 0.068G Lawn Herbicide + Fertilizer.
Active ingredient: Herbicide with Aminocyclopyrachlor at 0.068%.
Proposed use: Broadleaf weed control in residential lawns. Contact:
Mindy Ondish,<PHONE_NUMBER><EMAIL_ADDRESS>    37. File Symbol: 432-RUOL. Docket Number: EPA-HQ-OPP-2009-0636.
Applicant: Bayer Environmental Science, A Business Group of Bayer
CropScience, LP, P.O. Box 12014, 2 T.W. Alexander Drive, Research
Triangle Park, NC 27709. Product name: BCS-AA10717 0.0142% Plus Turf
Fertilizer Herbicide. Active ingredient: Herbicide with Indaziflam at
0.0142%. Proposed use: Pre-emergent herbicide on fertilizer for the
control of annual grasses, annual sedges, and broadleaf weeds in turf.
Contact: Erik Kraft,<PHONE_NUMBER><EMAIL_ADDRESS>    38. File Symbol: 432-RUOA. Docket Number: EPA-HQ-OPP-2009-0636.
Applicant: Bayer Environmental Science, A Business Group of Bayer
CropScience, LP, P.O. Box 12014, 2 T.W. Alexander Drive, Research
Triangle Park, NC 27709. Product name: BCS-AA10717 0.0213% Plus Turf
Fertilizer Herbicide. Active ingredient: Herbicide with Indaziflam at
0.0213%. Proposed use: Pre-emergent herbicide on fertilizer for the
control of annual grasses, annual sedges, and broadleaf weeds in turf.
Contact: Erik Kraft,<PHONE_NUMBER><EMAIL_ADDRESS>    39. File Symbol: 432-RUOT. Docket Number: EPA-HQ-OPP-2009-0636.
Applicant: Bayer Environmental Science, A Business Group of Bayer
CropScience, LP, P.O. Box 12014, 2 T.W. Alexander Drive, Research
Triangle Park, NC 27709. Product name: BCS-AA10717 0.0284% Plus Turf
Fertilizer Herbicide. Active ingredient: Herbicide with Indaziflam at
0.0284%. Proposed use: Pre-emergent herbicide on fertilizer for the
control of annual grasses, annual sedges, and broadleaf weeds in turf.
Contact: Erik Kraft,<PHONE_NUMBER><EMAIL_ADDRESS>    40. File Symbol: 432-RUOI. Docket Number: EPA-HQ-OPP-2009-0636.
Applicant: Bayer Environmental Science, A Business Group of Bayer
CropScience, LP, P.O. Box 12014, 2 T.W. Alexander Drive, Research
Triangle Park, NC 27709. Product name: BCS-AA10717 2% MUP Herbicide.
Active ingredient: Herbicide with Indaziflam at 2.0%. Proposed use: For
formulation into herbicide products intended for control of weeds in
turfgrass, ornamentals, nurseries, Christmas trees, landscape
plantings, forestry, and hardscapes in non-crop areas. Contact: Erik
Kraft,<PHONE_NUMBER><EMAIL_ADDRESS>    41. File Symbol: 432-RUOO. Docket Number: EPA-HQ-OPP-2009-0636.
Applicant: Bayer Environmental Science, A Business Group of Bayer
CropScience, LP, P.O. Box 12014, 2 T.W. Alexander Drive, Research
Triangle Park, NC 27709. Product name: BCS-AA10717 20WSP Herbicide.
Active ingredient: Herbicide with Indaziflam at 20.0%. Proposed use:
Pre-emergent herbicide for the control of annual grasses, annual
sedges, and broadleaf weeds in turfgrass, ornamentals, nurseries,
Christmas trees, landscape plantings, forestry, and hardscapes in non-
crop areas. Contact: Erik Kraft,<PHONE_NUMBER><EMAIL_ADDRESS>    42. File Symbol: 432-RLNR. Docket Number: EPA-HQ-OPP-2009-0636.
Applicant: Bayer Environmental Science, A Business Group of Bayer
CropScience, LP, P.O. Box 12014, 2 T.W. Alexander Drive, Research
Triangle Park, NC 27709. Product name: BCS-AA10717 Herbicide Technical.
Active ingredient: Herbicide with Indaziflam at 95.8%. Proposed use:
For formulation into herbicide products intended for the control of
weeds in turfgrass, ornamentals, nurseries, Christmas trees, landscape
plantings, forestry, hardscapes in non-crop areas, citrus fruits, pome
fruits, stone fruits, grapes, tree nuts, pistachios, and olives.
Contact: Bethany Benbow,<PHONE_NUMBER><EMAIL_ADDRESS>    43. File Symbol: 432-RLNI. Docket Number: EPA-HQ-OPP-2009-0636.
Applicant: Bayer Environmental Science, A Business Group of Bayer
CropScience, LP, P.O. Box 12014, 2 T.W. Alexander Drive, Research
Triangle Park, NC 27709. Product name: Esplanade 200 SC Herbicide.
Active ingredient: Herbicide with Indaziflam at 19.05%. Proposed use:
Pre-emergent herbicide for the control of annual grasses and broadleaf
weeds in non-crop areas, railroad and rail yards, managed roadsides,
established ornamental and perennial plantings, fence rows, utilities,
hardscapes, and other industrial, municipal, and government sites.
Contact: Bethany Benbow,<PHONE_NUMBER><EMAIL_ADDRESS>    44. File Symbol: 432-RLNO. Docket Number: EPA-HQ-OPP-2009-0636.
Applicant: Bayer Environmental Science, A Business Group of Bayer
CropScience, LP, P.O. Box 12014, 2 T.W. Alexander Drive, Research
Triangle Park, NC 27709. Product name: Esplanade F Herbicide. Active
ingredient: Herbicide with Indaziflam at 19.05%. Proposed use: Pre-
emergent herbicide for the control of annual grasses and broadleaf
weeds in forest areas. Contact: Bethany Benbow,<PHONE_NUMBER>,
<EMAIL_ADDRESS>    45. File Symbol: 59639-RLU. Docket Number: EPA-HQ-OPP-2009-0205.
Applicant: Valent U.S.A. Corporation, P.O. Box 8025, Walnut Creek, CA
94596-8025. Product name: Imazosulfuron Technical. Active ingredient:
Herbicide with Imazosulfuron at 99.5%. Proposed use: For formulation
into herbicide products intended for use in/on bare ground non-crop
areas, conifers, deciduous trees, non-bearing fruit and nut trees,
ornamentals, turfgrass, peppers (bell and non-bell), tomatoes, and
rice. Contact: Bethany Benbow,<PHONE_NUMBER><EMAIL_ADDRESS>

    46. File Symbol: 59639-RAA. Docket Number: EPA-HQ-OPP-2009-0205.
Applicant: Valent U.S.A. Corporation, P.O. Box 8025, Walnut Creek, CA
94596-8025. Product name: V-10142 AG Herbicide. Active ingredient:
Herbicide with Imazosulfuron at 75.0%. Proposed use: A selective
herbicide for the control and/or suppression of certain weeds in
tomatoes, peppers (bell and non-bell), and rice. Contact: Bethany
Benbow,<PHONE_NUMBER><EMAIL_ADDRESS>    47. File Symbol: 59639-RLL. Docket Number: EPA-HQ-OPP-2009-0205.
Applicant: Valent U.S.A. Corporation, P.O. Box 8025, Walnut Creek, CA
94596-8025. Product name: V-10142 Herbicide. Active ingredient:
Herbicide with Imazosulfuron at 75.0%. Proposed use: A selective
herbicide for the control of nutsedge and other weeds in established
turfgrass, around established ornamentals and conifers, and to maintain
bare ground non-crop areas. Contact: Erik Kraft,<PHONE_NUMBER>,
<EMAIL_ADDRESS>    48. File Symbol: 63588-OR. Docket Number: EPA-HQ-OPP-2009-0717.
Applicant: K-I Chemical U.S.A., Inc. c/o Landis International, Inc.,
P.O. Box 5126, Valdosta, GA 31603-5126. Product name: Pyroxasulfone
Technical. Active ingredient: Herbicide with Pyroxasulfone at 99.2%.
Proposed use: For formulation only into registered end-use herbicide
products. Contact: Michael Walsh,<PHONE_NUMBER>,
<EMAIL_ADDRESS>    49. File Symbol: 63588-OE. Docket Number: EPA-HQ-OPP-2009-0717.
Applicant: K-I Chemical U.S.A., Inc. c/o Landis International, Inc.,
P.O. Box 5126, Valdosta, GA 31603-5126. Product name: Pyroxasulfone 85
WG. Active ingredient: Herbicide with Pyroxasulfone at 85.0%. Proposed
use: Herbicide for the control of weeds in field corn, popcorn, sweet
corn, soybeans, and winter wheat. Contact: Michael Walsh, (703) 308-
2972<EMAIL_ADDRESS>    50. File Symbol: 63588-OG. Docket Number: EPA-HQ-OPP-2009-0717.
Applicant: K-I Chemical U.S.A., Inc. c/o Landis International, Inc.,
P.O. Box 5126, Valdosta, GA 31603-5126. Product name: V-10233
Herbicide. Active ingredient: Herbicide with Pyroxasulfone at 42.5% and
Flumioxazin at 33.5%. Proposed use: Herbicide for the control and/or
suppression of certain weeds in field corn, soybeans, fallow land, non-
crop areas around farms, orchards, vineyards, and to maintain bare
ground in non-crop areas. Contact: Michael Walsh,<PHONE_NUMBER>,
<EMAIL_ADDRESS>    51. File Symbol: 72155-IO. Docket Number: EPA-HQ-OPP-2009-0636.
Applicant: Bayer Advanced, 2 T.W. Alexander Drive, Research Triangle
Park, NC 27709. Product name: Lawn 3FL Herbicide Concentrate/Ready-to-
Spray. Active ingredient: Herbicide with Indaziflam at 0.25%, 2,4-D at
4.89%, Dicamba at 0.54%, and MCPP-p at 1.15%. Proposed use: Herbicide
for the control of annual grasses, annual sedges, and broadleaf weeds
in turf. Contact: Erik Kraft,<PHONE_NUMBER><EMAIL_ADDRESS>    52. File Symbol: 72155-ON. Docket Number: EPA-HQ-OPP-2009-0636.
Applicant: Bayer Advanced, 2 T.W. Alexander Drive, Research Triangle
Park, NC 27709. Product name: Lawn 3FL Herbicide Ready-to-Use. Active
ingredient: Herbicide with Indaziflam at 0.0031%, 2,4-D at 0.309%,
Dicamba at 0.034%, and MCPP-p at 0.073%. Proposed use: Herbicide for
the control of annual grasses, annual sedges, and broadleaf weeds in
turf. Contact: Erik Kraft,<PHONE_NUMBER><EMAIL_ADDRESS>    53. File Symbol: 72155-OR. Docket Number: EPA-HQ-OPP-2009-0636.
Applicant: Bayer Advanced, 2 T.W. Alexander Drive, Research Triangle
Park, NC 27709. Product name: Lawn 3FL Herbicide Granule. Active
ingredient: Herbicide with Indaziflam at 0.05%, Dicamba at 0.11%, and
Penoxsulam at 0.06%. Proposed use: Herbicide for the control of annual
grasses, annual sedges, and broadleaf weeds in turf. Contact: Erik
Kraft,<PHONE_NUMBER><EMAIL_ADDRESS>    54. File Symbol: 72155-OR. Docket Number: EPA-HQ-OPP-2009-0636.
Applicant: Bayer Advanced, 2 T.W. Alexander Drive, Research Triangle
Park, NC 27709. Product name: Lawn 3FL Herbicide Granule. Active
ingredient: Herbicide with Indaziflam at 0.05%, Dicamba at 0.11%, and
Penoxsulam at 0.06%. Proposed use: Herbicide for the control of annual
grasses, annual sedges, and broadleaf weeds in turf. Contact: Erik
Kraft,<PHONE_NUMBER><EMAIL_ADDRESS>    55. File Symbol: 86833-R. Docket Number: EPA-HQ-OPP-2009-0800.
Applicant: The Humane Society of the United States, 2100 L St., NW,
Washington, DC 20037. Poduct name: ZonaStat-H. Active ingredient:
Contraceptive with Porcine zona pellucida at 0.1%. Proposed use:
Contraceptive for the use in limiting populations of wild and feral
horses and burros. Contact: Jennifer Gaines,<PHONE_NUMBER>,
<EMAIL_ADDRESS>
List of Subjects

    Environmental protection, Pesticides and pest.

    Dated: January 19, 2010
 Lois Rossi,
Director, Registration Division, Office of Pesticide Programs.

[FR Doc. 2010-1579 Filed 1-26-10; 8:45 am]
BILLING CODE 6560-50-S